Obagi Skintrinsiq Clarifiying Protocol

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Obagi Skintrinsiq Clarifiying Protocol
Generic name: SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE
Manufacturer: Obagi Cosmeceuticals LLC
Product type: HUMAN OTC DRUG
SPL set ID: 08ba9ea8-73fd-472b-9cc4-67df167352ec
SPL ID: a9c17c57-a3af-43d6-9db3-56fb8e28894b
Version: 3
Effective date: 2025-03-21
Source export date: 2026-10-12
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:47:36

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 15 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M020	openfda.application_number
brand name		Obagi Skintrinsiq Clarifiying Protocol	openfda.brand_name
generic name		SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE	openfda.generic_name
manufacturer name		Obagi Cosmeceuticals LLC	openfda.manufacturer_name
ndc	package	62032-909-09	openfda.package_ndc
ndc	package	62032-612-04	openfda.package_ndc
ndc	package	62032-811-09	openfda.package_ndc
ndc	product	62032-909	openfda.product_ndc
ndc11	package	62032081109	derived:openfda.package_ndc
ndc11	package	62032090909	derived:openfda.package_ndc
ndc11	package	62032061204	derived:openfda.package_ndc
rxcui		251577	openfda.rxcui
rxcui		1235208	openfda.rxcui
spl id		a9c17c57-a3af-43d6-9db3-56fb8e28894b	id
spl set id		08ba9ea8-73fd-472b-9cc4-67df167352ec	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Warnings For external use only When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Stop use and ask a doctor if irritation becomes severe. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

warnings

Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask doctor if rash occurs Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Obagi Skintrinsiq Clarifiying Protocol

openFDA label record#

Harmonized identifier links#

Related Records#

Warnings cross-check#

warnings

warnings

Reported adverse events (FAERS/openFDA)#